$DRTS +11% at $14.86
Pre-market watch.
Squeeze 2/10 · WAIT FOR FAILURE · Foreign risk
9 months median follow-up, while Stock Titan references eight alive at cutoff; the encouraging but small early dataset makes catalyst-blind shorting unattractive.
147
$AIMD +11% at $1.37
Pre-market watch.
Squeeze 7/10 · HTB · WAIT FOR FAILURE
1 million three-year ASE contract, giving shorts a real commercial narrative to respect.
70
$OPTT +12% at $0.36
Pre-market watch.
Squeeze 4/10 · WAIT FOR FAILURE · Delist risk
50 per package; financing creates supply risk, but the warrant-inclusive price is not a standalone common-share valuation anchor.
58
$IMTE +13% at $0.41
Pre-market watch.
Squeeze 4/10 · WAIT FOR FAILURE · Foreign risk · Delist risk
No clear catalyst explains the gap.
43
$CRDF +15% at $0.84
Pre-market watch.
Squeeze 3/10 · WAIT FOR FAILURE
Cardiff's release carried by Yahoo Finance announces FDA Fast Track designation for onvansertib in first-line RAS-mutated metastatic colorectal cancer.
73
$GP +21% at $1.41
Pre-market watch.
Squeeze 6/10 · WAIT FOR FAILURE · Foreign risk · Delist risk
Stock Titan reports just 391.
74
$LXEO +23% at $3.53
Pre-market watch.
Squeeze 3/10 · WAIT FOR FAILURE
Lexeo's release carried by Yahoo Finance announces positive interim Phase I/II LX2020 data in PKP2 arrhythmogenic cardiomyopathy.
90
$GIPR +23% at $0.27
Pre-market watch.
Squeeze 9/10 · HTB · SQUEEZE TRAP · Delist risk
3 million warrant exercise transaction, leaving shorts facing financing-related supply but severe microfloat squeeze risk.
85
$HIHO +40% at $1.10
Pre-market watch.
Squeeze 7/10 · ETB · SQUEEZE TRAP · China risk · Delist risk
Highway Holdings' announcement.
68
$CLRO +44% at $4.84
Pre-market watch.
Squeeze 10/10 · HTB · SQUEEZE TRAP
68% reported short interest and a sub-million-share float make fresh shorts vulnerable.
140










